Brooks West

Volcano Corporation (NASDAQ: VOLC) is unlikely to attract a sweeter deal than the one it agreed to Wednesday with Royal Philips, according to a couple of analysts. Volcano, which makes surgical tools for angioplasty, inked a $1 billion deal with Philips that equals $18 a share and is slated to...

In a report published Wednesday, Piper Jaffray analyst Brooks West reiterated an Overweight rating on Medtronic (NYSE: MDT) and raised the price target from $58.00 to $68.00. In the report, Piper Jaffray says "Medtronic delivered 3.3% cc revenue growth in F2Q14 (Oct) with revenue of $4.194B...